Men taking androgen deprivation therapy (ADT) for prostate cancer were almost twice as likely to be diagnosed with Alzheimer’s disease in the years that followed than those who didn’t undergo the therapy, an analysis of medical records from two large hospital systems by Penn Medicine and Stanford University researchers has shown.
from Dementia Big http://ift.tt/1jLQyxO via aging and memory loss
http://ift.tt/1R867yu
No comments:
Post a Comment